Instituto de Biomedicina y Biotecnología de Cantabria -ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2021

  1. 5-HT4Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression

    ACS Chemical Neuroscience, Vol. 12, Núm. 11, pp. 2036-2044

  2. Autoradiographic Visualization of G Protein-Coupled Receptors in Brain

    Neuromethods (Humana Press Inc.), pp. 161-174

2018

  1. Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 4745-4762

2017

  1. Map3k8 modulates monocyte state and atherogenesis in ApoE -/- mice

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 37, Núm. 2, pp. 237-246

  2. Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas

    Journal of Investigative Dermatology, Vol. 137, Núm. 1, pp. 197-206

2016

  1. Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration

    Molecular Psychiatry, Vol. 21, Núm. 3, pp. 328-338

2014

  1. Serotonin 5-HT4 receptors: A new strategy for developing fast acting antidepressants?

    Current Pharmaceutical Design, Vol. 20, Núm. 23, pp. 3751-3762

  2. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation

    Leukemia, Vol. 28, Núm. 6, pp. 1334-1340

2013

  1. Region-specific regulation of 5-HT1B receptors in the rat brain by chronic venlafaxine treatment

    Psychopharmacology, Vol. 229, Núm. 1, pp. 177-185

2012

  1. Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT 4 receptor agonist RS67333

    International Journal of Neuropsychopharmacology, Vol. 15, Núm. 5, pp. 631-643

2011

  1. New strategies in the development of antidepressants: Towards the modulation of neuroplasticity pathways

    Current Pharmaceutical Design, Vol. 17, Núm. 5, pp. 521-533

2010

  1. Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine1A receptor-dependent mechanisms

    Molecular Pharmacology, Vol. 77, Núm. 3, pp. 424-434

  2. Reduced signal transduction by 5-HT 4 receptors after long-term venlafaxine treatment in rats

    British Journal of Pharmacology, Vol. 161, Núm. 3, pp. 695-706

2009

  1. Long-term treatment with fluoxetine induces desensitization of 5-HT 4 receptor-dependent signalling and functionality in rat brain

    Journal of Neurochemistry, Vol. 110, Núm. 3, pp. 1120-1127